The bivalent vaccine, manufactured by Moderna, targets both the original strain of covid which emerged in late 2019, and the first strain of Omicron which became dominant last winter. The UK became the first country to approve this new vaccine yesterday, and Moderna says it can supply millions of doses by the end of the […]
